Fingerprint
Dive into the research topics of 'Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers
Van K. Morris, Amir Jazaeri, Shannon N. Westin, Curtis Pettaway, Solly George, Ryan W. Huey, Michaela Grinsfelder, Aaron Shafer, Benny Johnson, David Vining, Ming Guo, Bryan Fellman, Michael Frumovitz
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations